Introduction {#tca13454-sec-0001}
============

Epithelioid hemangioendothelioma (EHE) is a rare sarcoma composed of dendritic and endothelial cells. The tumor is clinically and histologically intermediate between benign hemangioma and angiosarcoma and accounts for less than 1% of all vascular tumors. It is most commonly found in the liver, bone, and skin. EHE in the chest is extremely rare. This condition occurring in the sternum has not been reported until now. Given that EHE is aggressive, surgical resection with adjuvant chemotherapy and radiotherapy is recommended to prevent recurrence or metastasis.

Case report {#tca13454-sec-0002}
-----------

A 43‐year‐old man presented to our hospital with a chest mass accompanied by chest pain for over five months. The patient complained of slight haphalgesia and apparent tenderness radiating into the neck and shoulders, which was relieved by administering fenbid. The patient denied any history of trauma, and had no relevant medical history. On physical examination, a tumor 3 cm in diameter was found in the anterior chest wall. The preoperative thoracic computed tomography (CT) scan revealed a 3 cm × 2 cm mass in the sternum manubrium (Fig [1](#tca13454-fig-0001){ref-type="fig"}a). In addition, three‐dimensional (3D) reconstruction of the chest CT confirmed the presence of a sternal tumor (Fig [1](#tca13454-fig-0001){ref-type="fig"}b). A percutaneous thin‐needle aspiration biopsy was performed before the operation, and the primary diagnosis was mesenchymal tumor. Considering the particularity of sternal site and function, resection of the sternal tumor and a 3D‐printed titanium alloy graft implantation was planned which was approved by the Institutional Review Board of West China Hospital (No. 2018--45). Informed consent of the patient was obtained before surgery and the design of the 3D‐printed graft was performed using 3D reconstruction of the preoperative chest CT (Fig [2](#tca13454-fig-0002){ref-type="fig"}a). Consequently, the patient underwent an enlarged excision of the manubrium sternum with the surrounding muscle tissues and reconstruction of the chest wall with 3D‐printed titanium alloy sternal prosthesis under general anesthesia. The 3D‐printed sternal prosthesis consisted of two pairs of transverse limbs and a body. The limbs were fixed in the clavicle and the second rib, respectively, and the body in the sternum with screws (Fig [2](#tca13454-fig-0002){ref-type="fig"}b). Postoperative pathological examination confirmed the diagnosis of EHE. Hematoxylin and eosin staining showed some dendritic and endothelial cells formed various size vessels with red blood cells contained (arrows). There was also a dense inflammatory infiltration in some areas. (Fig [3](#tca13454-fig-0003){ref-type="fig"}a). Immunohistochemical staining was positive for CAMTA1, CD31, and CD34 (Fig [3](#tca13454-fig-0003){ref-type="fig"}b--d). Postoperative chest radiographs showed that the metal graft was in a normal position (Fig [4](#tca13454-fig-0004){ref-type="fig"}). After a successful postoperative recovery, he underwent radiotherapy, and no evidence of tumor recurrence was discovered during the one‐year follow up.

![(**a**) The preoperative thoracic computed tomography (CT) scan revealed a 3 cm × 2 cm mass in the sternum manubrium (red arrow). (**b**) The 3D reconstruction of the tumor (orange) of the sternum.](TCA-11-1741-g001){#tca13454-fig-0001}

![(**a**) The 3D printed design drawing before operation. (**b**) The 3D‐printed titanium alloy sternal prosthesis was implanted during the operation.](TCA-11-1741-g002){#tca13454-fig-0002}

![(**a**) Hematoxylin and eosin staining showed some dendritic and endothelial cells formed various size of vessels with red blood cells contained (arrows). There was also a dense inflammatory infiltration in some areas. (**b**--**d**) Immunohistochemical staining was positive for CAMTA, CD31 and CD34 proteins.](TCA-11-1741-g003){#tca13454-fig-0003}

![Postoperative chest radiographs showed that the metal graft was in a normal position.](TCA-11-1741-g004){#tca13454-fig-0004}

Discussion {#tca13454-sec-0003}
==========

EHE, a rare low‐moderate malignant hemangioma, was first described by Weiss in 1982.[1](#tca13454-bib-0001){ref-type="ref"} Clinically and histologically, EHE is considered an intermediate malignancy between angiosarcoma and hemangioma. According to reports in the literature, the incidence is less than one in a million, [2](#tca13454-bib-0002){ref-type="ref"} and it can occur at any age, especially in the 20s. Clinically, EHE mostly occurs in soft tissues, the liver, bone, and other organs.[3](#tca13454-bib-0003){ref-type="ref"} Review of the literature revealed rare involvement of the chest wall. To the best of our knowledge, our case is the first report of sternal EHE. The symptoms of EHE usually depend on the site of the disease, such as abdominal pain (liver) and dry cough (lung). The clinical presentation of sternal EHE is nonspecific and varies depending on the size of the tumor, which is similar to other common chest wall tumors. Patients may present with swelling and pain in the chest wall.

Radiological examination has great clinical value for the early discovery of ETE. The CT image of osseous EHE presents a multifocal lytic abnormality with osseous expansion, sclerotic margins, and a lack of periostitis. However, the diagnosis of EHE needs to be confirmed by pathology and immunohistochemistry. Pathologically, the tumor is composed of dendritic and endothelial cells with positive nuclear staining, and positive immunohistochemistry for vascular markers (CD31, CD34, and vimentin) can show better specificity. In addition, the WWTR1‐CAMTA1 characteristic fusion gene is regarded as an auxiliary diagnosis. The main differential diagnosis of EHE includes metastatic signet‐ring cell adenocarcinoma and epithelioid angiosarcoma.[4](#tca13454-bib-0004){ref-type="ref"}

EHE in the chest is extremely rare. The literature review (Table [1](#tca13454-tbl-0001){ref-type="table"}) reveals that the most common sites in the chest are lungs, mediastinum, and pleura.[5](#tca13454-bib-0005){ref-type="ref"}, [6](#tca13454-bib-0006){ref-type="ref"}, [7](#tca13454-bib-0007){ref-type="ref"}, [8](#tca13454-bib-0008){ref-type="ref"}, [9](#tca13454-bib-0009){ref-type="ref"}, [10](#tca13454-bib-0010){ref-type="ref"}, [11](#tca13454-bib-0011){ref-type="ref"}, [12](#tca13454-bib-0012){ref-type="ref"}, [13](#tca13454-bib-0013){ref-type="ref"}, [14](#tca13454-bib-0014){ref-type="ref"}, [15](#tca13454-bib-0015){ref-type="ref"}, [16](#tca13454-bib-0016){ref-type="ref"}, [17](#tca13454-bib-0017){ref-type="ref"}, [18](#tca13454-bib-0018){ref-type="ref"} Rare cases occurring in the <http://xueshu.baidu.com/usercenter/paper/show?paperid=7bd80dbe6b85c1871c62432d37adfb65&site=xueshu_se> and the superior vena cava have also been reported.[19](#tca13454-bib-0019){ref-type="ref"}, [20](#tca13454-bib-0020){ref-type="ref"} To date, this condition occurring in the sternum has not been reported. Surgical resection is generally accepted as the definitive treatment of choice for tumor of the chest wall. After resection of the sternal tumor, sternal reconstruction is necessary to protect the exposed thoracic viscera, repair the appearance of the chest wall, and maintain arm function. Available materials include titanium mesh or plate, autogenous bone graft, cryopreserved sternal allograft, or homograft flap.[21](#tca13454-bib-0021){ref-type="ref"}, [22](#tca13454-bib-0022){ref-type="ref"} However, 3D‐printed titanium alloy grafts have the advantages of individualization, easy fixation, and light tissue rejection. The clinical course of EHE is usually somewhat indolent compared with other sarcomas, and the five‐year survival is about 73%. Postoperative adjuvant radiotherapy is usually required to prevent recurrence and metastasis.[3](#tca13454-bib-0003){ref-type="ref"}, [23](#tca13454-bib-0023){ref-type="ref"}

###### 

Reported cases of epithelioid hemangioendothelioma (EHE) in the chest

  N    Author                                                            Age   Sex   Location      Size (cm)         Symptoms                  Treatment                          Follow‐up
  ---- ----------------------------------------------------------------- ----- ----- ------------- ----------------- ------------------------- ---------------------------------- ----------------------
  1    *Kumar et al*. [5](#tca13454-bib-0005){ref-type="ref"}            63    M     Lung          15 × 15 × 4       Chest pain, cough         Surgical resection                 No recurrence
  2    Agaimy *et al*.[6](#tca13454-bib-0006){ref-type="ref"}            62    M     Mediastinum   10 × 9 × 7        Dyspnea, cough            Surgical resection                 No recurrence
  3    Isowa *et al*.[7](#tca13454-bib-0007){ref-type="ref"}             41    M     Mediastinum   3.4 × 2.7         No                        Surgical resection                 No recurrence
  4    Val‐Bernal *et al*.[8](#tca13454-bib-0008){ref-type="ref"}        69    F     Heart         4 × 3 × 2         Dyspnea, orthopnea        Surgical resection                 No recurrence
  5    Lisy *et al*.[9](#tca13454-bib-0009){ref-type="ref"}              61    M     Heart         3 × 3             Abdominal pain            Surgical resection                 No recurrence
  6    Safirstein *et al*.[10](#tca13454-bib-0010){ref-type="ref"}       51    F     Heart         5 × 4 × 4         None                      Surgical resection                 No recurrence
  7    Márquez‐Medina *et al*.[11](#tca13454-bib-0011){ref-type="ref"}   85    M     Pleura        15 × 15 × 4       Chest pain, cough         Surgical resection                 No recurrence
  8    Lee *et al*.[12](#tca13454-bib-0012){ref-type="ref"}              31    F     Lung, bone    5 × 3 × 2.5       Dull pain                 Chemotherapy                       No recurrence
  9    Kim *et al*.[13](#tca13454-bib-0013){ref-type="ref"}              46    F     Pleura        No stated         chest discomfort, cough   Pleurectomy; Chemotherapy          Died after 23 months
  10   Mizota *et al*.[14](#tca13454-bib-0014){ref-type="ref"}           59    F     Lung          2.5 × 3.5         Cough, dyspnea            Surgical resection; chemotherapy   Recurrence
  11   Bansal *et al*.[15](#tca13454-bib-0015){ref-type="ref"}           51    F     Pleura        No stated         Chest pain, weight loss   Surgical resection; chemotherapy   Died after l4 months
  12   Campos *et al*.[16](#tca13454-bib-0016){ref-type="ref"}           36    F     Mediastinum   5.4               Dyspnea, dry cough        Surgical resection                 No recurrence
  13   Kumar *et al*.[17](#tca13454-bib-0017){ref-type="ref"}            33    M     Mediastinum   3.9 × 7.3 × 5.8   Chest and back pain       No                                 Died
  14   Wethasinghe *et al*.[18](#tca13454-bib-0018){ref-type="ref"}      41    M     Mediastinum   1.2 × 2.5         Chest pain, weight loss   radiotherapy                       No recurrence

In conclusion, EHE in the chest are extremely rare, and there are no cases in the sternum having been described in the literature to date. Preoperative diagnosis of sternal EHE is difficult, since clinical symptoms and radiology features overlap with other tumors arising from the chest wall. Here, we report a very rare case of EHE occurring in the sternum. Due to the lack of the evidence in the current literature, the therapeutic effect cannot be exactly assessed and close follow‐up is necessary.
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